| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |